Bioventus (BVS) Operating Income Growth (5y) (2025 - 2026)

Bioventus (BVS) Operating Income Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 Bioventus 837.84 Mn 801.99 Mn 90.77 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 -17.48%
Dec 31, 2025 26.96%
Sep 27, 2025 10.17%
Jun 28, 2025 43.09%
Mar 29, 2025 -17.82%